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Abstract
Background: Astrocyte-mediated neuroinflammation plays a critical role in ischemic stroke-induced secondary
cerebral injury. Previous studies have suggested that the dopamine D2 receptor (DRD2) acts as a key target in
regulating the neuroinflammatory response. However, the underlying molecular mechanisms are still unknown, and
effective DRD2 agonists are lacking. In the present study, we examined the anti-inflammatory and neuroprotective
effects of sinomenine (Sino), a monomeric compound with potential immunoregulatory properties in nervous system.
Methods: TTC staining, apoptosis assay, evaluation of brain edema, and neurological assessment were performed in
the middle cerebral artery occlusion (MCAO) mouse model. Primary astrocytes exposed to oxygen glucose deprivation
(OGD) were used in the in vitro experiments. Quantitative PCR was applied to assess the levels of inflammatory
cytokines. Multi-labeling immunofluorescence, Western blot, co-immunoprecipitation, and electrophoretic mobility shift
assay (EMSA) were also used to investigate the molecular mechanisms underlying the Sino-mediated anti-inflammatory
effects in vivo and in vitro.
Results: Sino remarkably attenuated the cerebral infarction and neuronal apoptosis, reduced the levels of inflammatory
cytokines, and alleviated neurological deficiency in MCAO mice. Sino significantly inhibited astrocytic activation and
STAT3 phosphorylation as well as increased DRD2 and αB-crystallin (CRYAB) expression after MCAO. In vitro, Sino
blocked OGD-induced activation of STAT3 and generation of pro-inflammatory cytokines in primary astrocytes, and
these effects were significantly abolished by either DRD2 or CRYAB knockdown. Additionally, Sino induced up-
regulation and nuclear translocation of CRYAB in astrocytes and enhanced the interaction between CRYAB and STAT3,
which further inhibited the activation and DNA-binding activity of STAT3.
Conclusions: Our study demonstrates that Sino activates astrocytic DRD2 and thereby suppresses neuroinflammation
via the CRYAB/STAT3 pathway, which sheds some light on a promising therapeutic strategy for ischemic stroke.
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Background
Ischemic stroke is one of the leading causes of morbid-
ity and mortality in adults worldwide and accounts for
approximately 87 % of all stroke cases [1]. Although
rapid reperfusion is a critical treatment strategy for is-
chemic stroke, it can paradoxically lead to exacerbated
cerebral ischemia and reperfusion (IR) injury. The
mechanisms of IR injury involve various pathophysio-
logical processes, among which inflammation has been
confirmed by increasing evidences [2, 3]. Thus, modu-
lating inflammatory signals may be a potential thera-
peutic approach for the treatment of ischemic stroke.
Astrocytes are the most numerous glial cells in the
brain and play critical roles in maintaining homeostasis
in the central nervous system (CNS). They are dynamic-
ally involved in the establishment and maintenance of
the blood-brain barrier, trophic support of neurons,
ionic and metabolic homeostasis, antioxidant defense,
and synaptic transmission [4–8]. In addition, astrocytes
can also secrete a series of pro-inflammatory and anti-
inflammatory cytokines to modify the ambient micro-
environment [9–11]. Accumulating evidences indicate
that astrocyte-mediated post-ischemic inflammation
contributes to the brain injury [12]. Cerebral ischemia
activates astrocytes to release various pro-inflammatory
cytokines, such as tumor necrosis factor-alpha (TNF-α)
and interleukin-1β (IL-1β), which are crucial for the
pathological processes of brain ischemic injury [13].
Recently, studies have demonstrated that activation of
the astrocytic dopamine D2 receptor (DRD2) suppressed
neuroinflammation in intracerebral hemorrhage and 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-in-
duced neurotoxicity [14, 15]. Additionally, αB-crystallin
(CRYAB), a heat-shock protein, has been shown to
possess anti-inflammatory properties and regulate the
astrocytic DRD2-mediated anti-inflammatory pathway in
both neurodegenerative disorders and cerebral injury
models [14, 16, 17]. These studies suggest astrocytes and
DRD2 as potential cellular and molecular targets for the
experimental and clinical treatment of inflammatory
injury in the CNS.
Sinomenine (Sino) is a bioactive alkaloid originally
extracted from the Chinese medicinal herb Sinomenium
acutum [18]. Sino possesses anti-inflammatory and
immunoregulatory properties and has long been used
for treating rheumatoid arthritis (RA) in China. In
addition, Sino protects against acute lung injury induced
by lipopolysaccharide (LPS) [19]. Sino was shown to
modulate a series of inflammation-related molecules,
including nitric oxide, TNF-α, leukotriene C4, and prosta-
glandin E3, in LPS-treated macrophages in vitro and in
vivo [20, 21]. Sino also decreased the expression of TNF-α
and IL-1β in adjuvant-induced arthritic rats [22]. Add-
itionally, a study in kidney IR injury has demonstrated its
potential anti-inflammatory role through suppressing
nuclear factor-kB transcriptional activity. However,
whether or not Sino exerts protective effect against
cerebral ischemic injury and if any the underlying
mechanisms are still unknown.
In the present study, we explored the role of Sino and the
underlying mechanisms in cerebral ischemic injury. Our
results indicated that Sino suppresses the neuroinflamma-
tion via targeting the astrocytic DRD2/CRYAB/STAT3
pathway in cerebral ischemic model in vivo and in vitro,
which sheds some light on a promising therapeutic strategy
for ischemic stroke.
Methods
Animal preparation and MCAO modeling
The adult C57BL/6 mice (20~25 g) used in the present
study were obtained from the Laboratory Animal
Center of the Fourth Military Medical University. All
the procedures and ethics guidelines were approved by
the Committee for Experimental Animal Use and Care
of the Fourth Military Medical University, China.
Efforts were made to minimize the number of animals
used and their suffering.
The middle cerebral artery occlusion (MCAO) surgery
was performed as previously reported [23, 24]. Briefly,
the mice were anesthetized with 1.5–2 % isoflurane
mixed with oxygen and nitrogen. A silicone-coated 6-0
suture (Covidien, Mansfield, MA) was gently inserted
from the exposed external carotid artery stump to the
internal carotid artery and wedged into the circle of
Willis to obstruct the opening of the middle cerebral
artery. The distance from the bifurcation of the internal/
external carotid artery to the middle cerebral artery was
approximately 9 ± 1.0 mm. The filament was withdrawn
after 60 min of the obstruction. The sham operation was
identical but did not include the occlusion of the middle
cerebral artery.
Drug administration
Sino was injected intraperitoneally to mice 6 h after
MCAO surgery at doses of 10 and 20 mg/kg daily for
3 days. The injection time points were 6, 24, and 48 h
post MCAO. The sham group received the same volume
of saline intraperitoneally.
Measurement of cerebral infarction
Seventy-two hours after MCAO, the mice were given an
overdose of anesthesia and decapitated. The brains were
carefully removed, and 1-mm-thick coronal slices were
collected in pre-warmed 2 % triphenyltetrazolium chlor-
ide (TTC) (Sigma, St. Louis, MO, USA) in saline for
10 min, followed by 30 min of fixation in 4 % parafor-
maldehyde in PBS (pH 7.4) [25]. Then, the pictures were
analyzed with NIH ImageJ software to determine the
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infarct volume. Infarct size was expressed as a percent-
age of hemispheric volume.
Measurement of brain edema
The brain edema analysis was performed according to a
previously reported method [23]. Briefly, the wet brains
were weighed and then immediately dried at 95 °C
overnight. The brain water content was calculated as
([wet tissue weight − dry tissue weight] / wet tissue
weight) × 100 %.
Neurological injury severity assessment
The severity of neurological injury was assessed accord-
ing to a four-tiered grading system and a 21-point scor-
ing system named the Garcia test, as reported previously
[26, 27]. The trained investigators were blinded to the
control groups and drug-treatment groups in the test.
Primary astrocyte culture and transfection
Astrocytes were prepared from the cortex of C57BL/6
mice at P0, as described previously [14]. Briefly, the
neonatal cortical tissues were dissociated with trypsin, and
cells were plated at a density of 5 × 107 cells per 75 cm2
flask (Thermo Scientific) in DMEM/Ham’s F12 medium
containing 10 % fetal bovine serum (FBS). After 24 h, the
culture medium was changed to complete medium
(DMEM/F12 medium with 10 % FBS) and was subse-
quently changed twice per week. Cultures were shaken
at 200 rpm/min for 12–18 h to remove other types of
neuronal cells after 10 days. When the cells reached
70 % of confluence, they were transfected with small
interfering RNA (siRNA) for 72 h via Lipofectamine
(RNAi MAX Transfection Reagent, Thermo Scientific).
DRD2 siRNA and CRYAB siRNA were purchased from
Life Technologies. The sequences of the scramble control
siRNA were as follows: sense: r(UUCUCCGAACGUGU
CACGU) dTdT; and antisense: r(ACGUGACACGU-U
CGGAGAA) dTdT.
Oxygen glucose deprivation (OGD) management and
treatment
The procedures were performed in accordance with a
previously described protocol [28]. After purification
and siRNA transfection as described above, primary
astrocytes were cultured with deoxygenated DMEM
without glucose and FBS (Gibco, CA, USA) in an incu-
bator (Thermo Scientific) with premixed gas (1 % O2,
94 % N2, 5 % CO2) for 5 h. Then, the cells were given
normal DMEM (Gibco, CA, USA) containing 10 % FBS
and placed in a CO2 incubator (95 % air and 5 % CO2)
for 24 h. Cells in the control group were cultured with
normal DMEM and 10 % FBS for the same time. After
OGD induction, 0.01, 0.1, 1, 10 mM Sino was immedi-
ately used to treat astrocytes for 24 h.
Immunofluorescence and TUNEL staining
Histological assessment was performed on a fixed frozen
coronal section (25 μm) with a cryostat as described previ-
ously [29]. Fresh antibody dilution buffer (0.01 M PBS
containing 3 % normal goat serum and 0.3 % Triton X-
100) was used for immunofluorescence staining. Sections
were incubated at 4 °C overnight with diluted primary
antibodies as follows: mouse anti-GFAP (1:400, Cell Sig-
naling Technology), mouse anti-NeuN (1:1000, Abcam),
mouse anti-Iba1 (1:200, Abcam), goat anti-DRD2 (1:200,
Abcam), and rabbit anti-p-STAT3 (Tyr705) (1:200, Cell
Signaling Technology). The following secondary anti-
bodies were purchased from Abcam: donkey anti-mouse
IgG (Alexa Fluor 488/594), donkey anti-goat IgG (Alexa
Fluor 488/647), and donkey anti-rabbit IgG (Alexa Fluor
594). Images were obtained using a confocal laser micro-
scope system (FV1000, Olympus, Tokyo, Japan). Cells
were also fixed with 4 % paraformaldehyde for 10 min at
room temperature. The additional primary antibody was
anti-CRYAB (1:100, Abcam). The protocol for cell culture
staining was the same as that used for the brain sections.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) staining was performed
according to the instructions provided with a commer-
cial TUNEL staining kit (QIA39, Merck, Germany).
Photos were captured with a confocal microscope, and
the TUNEL-positive cells in the cerebral ischemic
penumbra were counted manually. TUNEL staining ana-
lysis was performed on five slices containing cortical
ischemic penumbra per mouse (n = 5) and five mice per
group (n = 5).
Western blot
Tissues containing ischemic penumbra were harvested
for Western blotting at 24, 48, 72 h after MCAO follow-
ing a standard protocol (Molecular Clone, Edition II).
Briefly, the tissues were lysed in 300 μL lysis buffer
(10 mM Tris, 150 mM NaCl, 1 % Triton X-100, 0.5 %
NP-40, 1 mM EDTA, pH 7.4) and mixed with protease
and phosphatase inhibitor cocktails (Roche). Nuclear
protein was obtained using nuclear and cytoplasmic
extraction reagents (Thermo Scientific). Twenty-five
micrograms of cell lysate, as quantified with a BCA pro-
tein assay (Pierce), was separated on SDS-PAGE and
transferred to PVDF membranes (Roche). The primary
antibodies used were as follows: anti-glial fibrillary acidic
protein (GFAP) (1:4000, Cell Signaling Technology),
anti-Iba1 (1:1000, Abcam), anti-DRD2 (1:2000, Abcam),
anti-p-STAT3 (Tyr705) (1:1000, Cell Signaling Technol-
ogy), anti-STAT3 (1:1000, Cell Signaling Technology),
anti-CRYAB (1:2000, Abcam), anti-β-actin (1:2000,
Abcam), and anti-histone 3 (1:2000, Cell Signaling Tech-
nology). The secondary HRP-labeled antibodies were all
from Cell Signaling Technology. Chemical reactions
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were detected with an ECL system (Advansta), and the
scanned images were analyzed with ImageJ software
(version 1.47). The protocols for cell culture experiments
were the same as those described above.
Quantitative PCR (qPCR)
The messenger RNA (mRNA) levels of inflammatory
cytokines were assessed with qPCR. The ischemic pen-
umbra tissues and cultured cells were homogenized on
ice, and the total RNA was extracted with Trizol
(Sigma). Complementary DNA (cDNA) was synthesized
from 1 μg total RNA with an iScript cDNA synthesis Kit
(Takara, Tokyo, Japan). Quantitative real-time PCR was
performed using a SYBR Premix Ex Taq kit (Takara,
Tokyo, Japan). The cycle threshold (Ct) values for IL-1β,
IL-6, IL-18, and TNF-α were determined in duplicate
and normalized to the endogenous control GAPDH.
The qPCR primers were designed using the Primer Pick-










The co-IP procedures were performed as previously de-
scribed [30]. Protein A/G PLUS-Agarose was purchased
from Santa Cruz Technology. The nuclear protein extracts
were precipitated with a STAT3 antibody and then ana-
lyzed by Western blot with STAT3, p-STAT3, and CRYAB
antibodies. STAT3 was used as the loading control in the
assay of immunoblot.
Electrophoretic mobility shift assay (EMSA)
A commercial EMSA Kit (Beyotime Biotechnology) was
used to detect the DNA-binding activity of STAT3
following the manufacturer’s instructions. The nuclear
protein was extracted as described above. Biotin-labeled
STAT3 consensus oligonucleotide probes and cold com-
petitors were used, and the oligonucleotide sequences
were: 5′-GAT CCT TCT GGG AAT TCC TAG ATC-3′,
3′-CTA GGA AGA CCC TTA AGG ATC TAG-5′. A
total of 20 μg nuclear extract proteins were mixed and
then incubated with STAT3 probes for 30 min at room
temperature. Samples with loading buffer were separated
on 6 % non-denaturing gels and transferred to the nitro-
cellulose membranes. The chemical reaction was detected
with an ECL system (Advansta, Menlo Park, CA, USA).
Statistical analysis
SPSS (version 19.0) software was used for data analysis in
this study. Comparisons among multiple groups were
assessed using one-way analysis of variance (ANOVA).
Student’s t test was used to make intergroup comparisons.
For neurological studies, two-way ANOVA was performed
for pairwise comparisons between different groups and
different periods of time. All the results are expressed as
mean ± standard error of mean (SEM). A value of p < 0.05
was considered to be statistically significant.
Results
Sino dose-dependently reduced ischemic infarct volume
and neuronal apoptosis in the MCAO mice
First, we explored the possible neuroprotective effects of
Sino in the MCAO mouse model. Cerebral infarction
was assessed by TTC staining 72 h after MCAO. Normal
brain tissue was stained red, while the infarct lesion
remained unstained (white). Compared with the vehicle
group, the brain infarct volume was decreased in the
Sino-10 (10 mg/kg, daily) and Sino-20 (20 mg/kg, daily)
groups (Fig. 1a, b). Moreover, the brain infarct volume
in the Sino-20 group was less than that in the Sino-10
group (p < 0.05). In accordance, the brain water content
in the sham group was 76.2 ± 0.43 %. The brain water
content in the vehicle group (83.7 ± 0.73 %) was higher
than that in the Sino-10 group (81.6 ± 0.69 %) and in the
Sino-20 group (77.3 ± 0.54 %) (Fig. 1c). Furthermore, the
TUNEL assay was employed to determine the anti-
apoptotic effect of Sino in the ischemic mice (Fig. 1e, f ).
Approximately 193 ± 23 cells stained by DAPI were
counted manually in the field per slice. More TUNEL-
positive apoptotic cells were observed in the vehicle
group than in the sham group (p < 0.01). The number of
TUNEL-positive cells in the Sino-treated groups was less
than that in the vehicle group (p < 0.05). In addition, the
number of apoptotic cells in the Sino-20 group was
markedly less than that in the Sino-10 group (p < 0.05).
Taken together, the above results indicated that Sino
dose-dependently reduced ischemic infarction volume
and neuronal apoptosis in the MCAO model.
Sino alleviated neurological impairment after ischemic
injury
Neurological scoring was conducted to evaluate
neurological behavior impairment in different groups
(Fig. 2a, b). The mice in the vehicle group exhibited
severe neurological deficits compared with the sham
group. However, Sino treatment alleviated neuro-
logical impairment after ischemic injury, and this
protective effect occurred in a dose-dependent man-
ner (p < 0.01, vehicle group vs. Sino-20 group; p < 0.05,
Sino-20 group vs. Sino-10 group).
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Sino inhibited MCAO-induced IL-1β, IL-6, IL-18, and TNF-α
production
The IL-1β, IL-6, IL-18, and TNF-α mRNA levels were
detected using qPCR. The levels of IL-1β, IL-6, IL-18,
and TNF-α in the vehicle group were significantly higher
than those in the sham group (p < 0.01) (Fig. 3a–d).
However, Sino markedly reduced the mRNA levels of
the aforementioned cytokines compared with the vehicle
treatment in a dose-dependent manner (p < 0.05, Sino-
10 group vs. vehicle group; p < 0.01, Sino-20 group vs.
vehicle group).
Effects of Sino on astrocytic activation, DRD2, p-STAT3
and CRYAB expression in MCAO mice
Images from the ipsilateral peri-infarct cortical area
(−1.7 to −1.9 mm from bregma) were captured with a
laser confocal microscope (Nikon, A1, Tokyo, Japan).
Fig. 1 Sino treatment reduced ischemic infarct volume and neuronal apoptosis in the MCAO model. a Cerebral infarct volume was
assessed via TTC staining 72 h after MCAO. The infarct volume ratio (b) and brain water content (c) were analyzed in each group. Data
are expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 and ##p < 0.01 vs. the indicated groups. The
ischemic penumbra area in the box (d) was assessed for neuronal apoptosis using TUNEL assay. e, f Images and quantitative analysis of
apoptosis. Green, TUNEL-positive cells; blue, DAPI. Data are expressed as mean ± SEM (n = 5). Scale bar = 100 μm. *p < 0.05 and **p < 0.01
vs. sham group; #p < 0.05 and ##p < 0.01 vs. the indicated groups
Fig. 2 Sino alleviated the neurological impairment of mice after MCAO. The neurological deficiency (a) and neurological score (b) of mice after
MCAO were assessed using a four-tiered grading system and a 21-point scoring system (Garcia test). Data are expressed as mean ± SEM (n = 8).
*p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 and ##p < 0.01 vs. the indicated groups
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Cells were double-labeled with DRD2 combing with
NeuN (neuronal marker), GFAP (astrocytic marker), or
Iba1 (microglial marker), respectively. The endogenous
DRD2 was up-regulated in neurons (NeuN/DRD2,
Fig. 4a), microglia (Iba1/DRD2, Fig. 4b), and astrocytes
(GFAP/DRD2, Fig. 4c) after MCAO. Sino treatment
further increased the DRD2 level in the above cells.
To unravel the potential roles of Sino and DRD2 in the
neuroinflammation induced by ischemic injury, we exam-
ined the activation status of glial cells (microglia and as-
trocytes). Astrocytic activation in the ischemic hemisphere
was significantly inhibited by Sino treatment (20 mg/kg,
daily), as indicated by the lower GFAP level detected with
immunofluorescence staining and Western blot (p < 0.05,
Sino-20 group vs. vehicle group) (Fig. 4c–e and Additional
file 1: Figure S5). However, neither the changes in Iba1
expression nor the changes in morphology (soma size and
ramification index) of Iba1-labeled microglia (Fig. 4b and
Additional file 1: Figure S7D-F) differed significantly
between the Sino-treated and MCAO groups. A flow
cytometry assay separating microglia (CD11b+CD45low)
and macrophages (CD11b+CD45high) in the ischemic
hemisphere after MCAO (Additional file 1: Figure S7B-C)
also showed that Sino treatment did not influence the
number of activated microglia after MCAO.
In addition, double-immunofluorescence staining also
showed that the astrocytic p-STAT3 level was signifi-
cantly increased after MCAO but was decreased by Sino
treatment (Fig. 4d).
The expression of GFAP, DRD2, p-STAT3, and CRYAB
were determined using Western blot (Fig. 4e–j). DRD2
was increased as early as 24 h after MCAO compared to
the sham group (p < 0.05). In addition, Sino further
significantly up-regulated DRD2 expression after MCAO
compared to the vehicle group (p < 0.01). A similar
expression pattern was observed in CRYAB. In contrast,
Sino significantly reversed the increase in p-STAT3
induced by MCAO.
DRD2 or CRYAB knockdown abolished the inhibitory
effect of Sino on neuroinflammation in OGD-induced
astrocytes
The different doses of Sino had no effect on the cell
viability (MTT assay) of primary astrocytes (Additional
file 1: Figure S1A). The anti-inflammatory effect was
observed in the 1 mM and 10 mM Sino groups (p < 0.05,
vs. vehicle group), and there was no significant differ-
ence between these two doses (Additional file 1: Figure
S1B). Therefore, 1 mM Sino was used in the following in
vitro tests.
Fig. 3 Sino suppressed MCAO-induced neuroinflammation. a–d qPCR analysis showing the relative mRNA levels of the pro-inflammatory
mediators IL-1β, IL-6, IL-18, and TNF-α. Data are expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 and
##p < 0.01 vs. the indicated groups
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To clarify the potential role of DRD2 and CRYAB in the
anti-inflammatory effect of Sino, we treated primary astro-
cytes with DRD2 siRNA and CRYAB siRNA. In addition,
the cells were maintained under OGD conditions to estab-
lish the ischemic in vitro model. Sino treatment signifi-
cantly reduced the mRNA levels of the pro-inflammatory
cytokines IL-1β, IL-6, IL-18, and TNF-α compared to the
vehicle group after OGD induction (p < 0.05), and this
effect was reversed by either DRD2 siRNA or CRYAB
siRNA pretreatment (p < 0.05, vs. Sino + scramble siRNA
group) (Fig. 5a–d).
Furthermore, the qPCR (Additional file 1: Figure
S2A-B) showed that the DRD2 knockdown astrocytes
produced higher mRNA levels of IL-1β than their
normal counterparts after OGD induction (p < 0.01).
In contrast, the expression of the same inflammatory
Fig. 4 Effects of Sino on the activation of astrocytes and microglia, and the expression of DRD2, p-STAT3, and CRYAB in MCAO mice. a–c
Double-immunofluorescence staining for neuronal (NeuN), microglial (Iba1), and astrocytic (GFAP) DRD2 expression in the ischemic
penumbra area after MCAO. d Double-immunofluorescence staining for astrocytic p-STAT3 and DAPI. The cells indicated with an arrow
were magnified. Scale bar = 200 μm. e–j Western blots and quantitative analysis of GFAP, Iba1, DRD2, p-STAT3, and CRYAB expression are
expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 between the indicated groups
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mediator was not significantly altered in the DRD2
knockdown BV2 microglia. In addition, Sino treat-
ment significantly reduced the OGD-induced IL-1β
mRNA level in astrocytes (p < 0.05), and this effect
was significantly blocked by DRD2 knockdown. How-
ever, these changes were not significant in microglia
in either the DRD2 normal or the knockdown group
(Additional file 1: Figure S2A-B).
Astrocytic morphology changes were detected with
GFAP staining (Fig. 6a). OGD-induced astrocytic activa-
tion was indicated by increased and lengthened cell pro-
tuberances. Sino inhibited the activation of astrocytes
after OGD induction, and this effect was weakened by
either DRD2 or CRYAB knockdown. To determine the
downstream targets of Sino in the anti-inflammatory
process, we examined the expression of DRD2, CRYAB,
and p-STAT3 in primarily cultured astrocytes. Com-
pared to the control group, OGD significantly increased
the levels of GFAP, DRD2, CRYAB, and p-STAT3 in the
vehicle group (p < 0.05, p < 0.01) (Fig. 6b–g). Sino mark-
edly reduced GFAP and p-STAT3 levels and increased
DRD2 and CRYAB levels after OGD (p < 0.05, p < 0.01).
These effects were blocked by either DRD2 or CRYAB
knockdown, as confirmed with immunofluorescence
staining and Western blot (Fig. 6b, c). Interestingly, Sino
significantly increased the nuclear expression of CRYAB
and inhibited the phosphorylation of STAT3 after OGD
in primary astrocytes, with the co-localization of CRYAB
and p-STAT3 in the nuclei (Fig. 6b, c). These effects
were abolished by either DRD2 siRNA or CRYAB siRNA
treatment. There was no difference between the Sino
group and the Sino + scramble siRNA group.
Sino induced the nuclear translocation of CRYAB and
attenuated the activation of STAT3 in astrocytes after
OGD induction
Sino treatment significantly increased the expression of
nuclear CRYAB in primary astrocytes after OGD induc-
tion (p < 0.01, Sino group vs. control group) (Fig. 7a, b).
However, DRD2 siRNA or CRYAB siRNA attenuated the
nuclear translocation of CRYAB after OGD (p < 0.05 vs.
control group). Co-IP (Fig. 7c–e) showed that Sino
enhanced the interaction between CRYAB and STAT3,
with increased expression of CRYAB in the immuno-
complex after OGD (p < 0.01, Sino group vs. control
group). Additionally, the higher CRYAB levels and the
Fig. 5 Sino suppressed OGD-induced inflammation in astrocytes in vitro. a–d qPCR analysis showing the relative mRNA levels of the pro-inflammatory
mediators IL-1β, IL-6, IL-18, and TNF-α. Data are expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 and ##p < 0.01 vs.
the indicated groups
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lower p-STAT3 levels were detected in the Sino
group. However, these effects were abolished in both
the DRD2 siRNA group and the CRYAB siRNA group
(p < 0.05, p < 0.01, vs. Sino group). The EMSA assay
(Fig. 7f, g) indicated that Sino treatment reduced the
DNA-binding activity of STAT3 after OGD induction
(p < 0.05, Sino group vs. control group), which was re-
versed by either DRD2 knockdown or CRYAB knock-
down (p < 0.05, vs. Sino group).
Discussion
Ischemic stroke is an important leading cause of mor-
bidity and mortality in adults worldwide, and emerging
evidences demonstrate that astrocytic inflammatory
responses plays a critical role in secondary brain injury
following ischemia [13, 31]. However, the lack of tar-
geted drugs impedes clinical stroke therapy. In the
present study, we demonstrated that Sino, a bioactive
alkaloid from the Chinese medicinal herb S. acutum,
significantly attenuated neuroinflammatory injury and
neurological deficits in cerebral ischemic mice. Sino
ameliorated the activation of astrocytes, the phosphoryl-
ation of STAT3, and increased DRD2 and αB-crystallin
(CRYAB) expression in vivo and in vitro, all of which
were significantly reversed by DRD2 and CRYAB
knockdown. We further found that Sino induced the
up-regulation and nuclear translocation of CRYAB in
astrocytes, and inhibited STAT3 activation by enhan-
cing the interaction between CRYAB and STAT3. Taken
together, our findings suggest that Sino exerts potent
therapeutic effects in cerebral ischemia by targeting
astrocytic DRD2 and suppressing neuroinflammatory
injury via the CRYAB/STAT3 pathway.
Neuroinflammation induced by astrocytes is one of
the primary causes of secondary brain injury [32]. How-
ever, there is a lack of effective therapeutics targeting
Fig. 6 The effects of Sino on the activation of astrocytes and the expression of astrocytic DRD2, CRYAB, and p-STAT3 after OGD induction in vitro.
a The morphology changes of astrocytes labeled with GFAP. b Multi-immunofluorescence staining for CRYAB, DRD2, and p-STAT3 in astrocytes
after OGD induction. Scale bar = 20 μm (a, b). c–g Western blots and quantitative analysis of GFAP, DRD2, p-STAT3, and CRYAB expression. Data
are expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group; #p < 0.05 and ##p < 0.01 vs. the indicated groups
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astrocytes in the clinical treatment. Sino has been suc-
cessfully used for rheumatoid arthritis treatment for
centuries in China [33]. Studies have shown that Sino
reduced the LPS-induced synthesis of prostaglandin E3,
leukotriene C, TNF-α, and nitric oxide in macrophages
and inhibited the proliferation of synovial fibroblasts and
lymphocytes stimulated with IL-1β. Sino suppressed is-
chemia/reperfusion-induced inflammatory infiltration
and the expression of CXCL-10, ICAM-1, and TNF-α/
IL-6 in kidney cells. In our study, we demonstrated that
Sino (20 mg/kg daily for 3 days) significantly alleviated
the neuronal damage by reducing cerebral infarction,
brain water content, and neuronal apoptosis in the is-
chemic hemisphere. We also observed the amelioration
of neurological deficits of the MCAO mice in the Sino-
treated groups. Our findings provided the first evidence
that Sino attenuates ischemic brain injury.
It was reported that Sino might exert protective effects
by inhibiting acid-sensing ion channel (ASIC) 1a, LDH,
and inflammatory factors in neurons and glia [34]. The
present study showed that Sino significantly decreased
the mRNA levels of pro-inflammatory cytokines, includ-
ing IL-1β, IL-6, IL-18, and TNF-α, in the tissues sur-
rounding the cerebral infarction (Fig. 3). However, the
specific targets of Sino in this anti-inflammatory effect
remain undetermined, and the molecular mechanisms of
its actions are largely unknown. Astrocytic activation
was detected in the penumbra after cerebral ischemia in
patients and experimental animal models [9, 35]. Recent
studies have demonstrated that astrocytic DRD2 modu-
lates neuroinflammation in the CNS, which suggested a
new strategy of suppressing the innate immune response
during aging and disease [14, 36]. In our study, we
observed significant astrocytic activation and DRD2 up-
regulation in the ischemic penumbra area after MCAO
(Fig. 4c). Sino remarkably inhibited the activation of astro-
cytes, rather than microglia, and significantly increased
DRD2 expression in astrocytes. However, the activation of
microglia after MCAO was not significantly influenced by
Sino treatment (Fig. 4b and Additional file 1: Figure S7).
We also demonstrated astrocytes were more hyper-
responsive in OGD-induced inflammation than microglia
when DRD2 was down-regulated. Our findings provided
evidence that astrocytic DRD2 mainly contributed to the
anti-inflammatory effect of Sino after cerebral ischemia.
To identify the downstream effectors of Sino in activating
DRD2 signaling in astrocytes, we detected the levels of the
endogenous anti-inflammatory protein CRYAB. We found
that Sino increased CRYAB expression both in vivo and in
vitro (Figs. 4e and 6c). In addition, we also demonstrated
that Sino increased nuclear expression of CRYAB in as-
trocytes, which suggested CRYAB might possess effects
of nuclear translocation and transcriptional regulation.
However, the mechanism underlying the negative
Fig. 7 The effects of Sino on the nuclear translocation of CRYAB and the activation of STAT3 in astrocytes in vitro. a, b Western blot and quantitative
analysis of nuclear CRYAB expression. c–e Immunoprecipitation assay evaluating the binding activity of CRYAB with STAT3 and the phosphorylation of
p-STAT3. f, g EMSA assay of the DNA-binding activity of STAT3. Data are expressed as mean ± SEM (n = 5). *p < 0.05 and **p < 0.01 vs. sham group
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effects of CRYAB on the inflammatory response is not
well understood.
The STAT3 signaling has been reported to play a crit-
ical role in inflammatory responses in the CNS [37].
STAT3 is activated by phosphorylation at Tyr705, which
induces STAT3 dimerization, nuclear translocation, and
DNA binding, resulting in the transcription of genes
encoding several inflammatory factors [37–40]. In our
study, we observed that astrocytic p-STAT3 was up-reg-
ulated after MCAO in vivo and after OGD in vitro, and
this effect was reversed by Sino treatment (Figs. 4 and 6).
In addition, both DRD2 knockdown and CRYAB knock-
down increased the p-STAT3 expression. These data
suggested that the activation of STAT3 might be involved
in the neuroinflammatory injury after MCAO and the
neuroprotective effect of Sino could be mediated by
DRD2/CRYAB signaling.
In addition, we found that Sino not only increased the
expression of CRYAB but also induced the nuclear
translocation of CRYAB in vitro after OGD induction
(Figs. 6a and 7a and Additional file 1: Figure S3). Add-
itionally, a higher level of nuclear CRYAB was associated
with lower level of STAT3 activation. The co-IP showed
that Sino enhanced the interaction between CRYAB and
STAT3, with a decrease in the level of p-STAT3 in the
immunocomplex. Such effects were abolished in both
the DRD2 siRNA group and the CRYAB siRNA group
(Fig. 7b). The EMSA assay (Fig. 7f ) showed that Sino
treatment reduced the DNA-binding activity of STAT3
after OGD induction, which was reversed by either
DRD2 knockdown or CRYAB knockdown in primary
astrocytes. Thus, we inferred that Sino suppressed neu-
roinflammation by inhibiting the phosphorylation of
STAT3 and blocking the DNA-binding activity of STAT3
in astrocytes via DRD2/CRYAB signaling. However,
microglial or neuronal DRD2 mechanisms cannot be
completely excluded, as some potential indirect neuro-
protective effects of Sino could still exist.
Conclusions
In summary, our study demonstrates that Sino possesses
potent therapeutic effects in cerebral ischemia and sup-
presses neuroinflammatory injury via targeting astrocytic
DRD2 and the CRYAB/STAT3 pathway. Our findings
also provide evidence for the clinical use of Sino in is-
chemic stroke treatment. The schematic diagram in Fig. 8
better illustrates our novel findings in the present study.
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Additional file 1: Figure S1. The effect of sinomenine on cell viability
and inflammation response in astrocytes. Figure S2. Astrocytes were
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expression of CRYAB in astrocytes. Figure S4. Blood-brain barrier (BBB)
disruption evaluation by Evans blue (EB) extravasation in sham and MCAO
mice. Figure S5. Effect of sinomenine on the number and activation of
astrocytes after MCAO. Figure S6. Immunological identification of
primary astrocyte culture. Figure S7. Effect of sinomenine on the number
and activation of microglia after MCAO. Flow cytometry. (DOCX 0.99 MB)
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